Connect with a Global Community of Cell & Gene Experts

With collaborations in the in vivo space and the anticipation of a therapeutic revolution, the excitement around the future of cell and gene therapies is at an all-time high. As we await an explosion of development and clinical progression, now is the time to showcase your solutions to a room of in vivo cell and gene decision-makers at the 4th In Vivo Cell Engineering & Gene Editing Summit.Β 

Trailblazing companies in the field are seeking collaborators to accelerate their path to the clinic. If you have top-tier solutions and services in the following:Β 

    • Preclinical model providersΒ 
    • Viral and non-viral vector technology providersΒ 
    • Antibody discovery for CAR construct designΒ 
  • AI-generated binders for targeted drug delivery
  • Transfection & raw material agents

...then drug developers are looking for you!

Get In Touch to Discuss Tailored Partnership Opportunities!

Why Partner with this Summit?

Shape the Future

Lead the revolution of therapies to combat cancer, genetic and rare diseases and establish yourself as a pioneering service provider at the forefront of ground-breaking change.

Connect with Key Decision Makers

Engage with pioneers shaping the future of in vivo cell engineering and gene editing therapies to forge strong business connections and lasting relationships to drive business growth.

Outpace Your Competitors

Gain exclusive insights into the latest developments and innovations directly from industry leaders into the future of the in vivo cell and gene space.

Boost Brand Visibility & Prestige

Position yourself as a trusted service provider, building lasting trust and credibility to elevate your reputation to new heights.

Explore Related Events

Introducing the Cell Therapies Event Series, a collection of 26 established events curated to enable this community to achieve their clinical and commercial potential.

58621 – Horizontal Background - 1a (1)

Having trouble downloading the brochure?Β Let us know here and we'll email it to you instead.